211 related articles for article (PubMed ID: 24744438)
1. Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.
Bachelet T; Couzi L; Pitard V; Sicard X; Rigothier C; Lepreux S; Moreau JF; Taupin JL; Merville P; Déchanet-Merville J
J Am Soc Nephrol; 2014 Nov; 25(11):2471-82. PubMed ID: 24744438
[TBL] [Abstract][Full Text] [Related]
2. Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.
Sablik KA; Litjens NHR; Klepper M; Betjes MGH
Transpl Immunol; 2019 Jun; 54():52-58. PubMed ID: 30794946
[TBL] [Abstract][Full Text] [Related]
3. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa).
Couzi L; Pitard V; Sicard X; Garrigue I; Hawchar O; Merville P; Moreau JF; Déchanet-Merville J
Blood; 2012 Feb; 119(6):1418-27. PubMed ID: 22180442
[TBL] [Abstract][Full Text] [Related]
5. Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients.
Déchanet J; Merville P; Bergé F; Bone-Mane G; Taupin JL; Michel P; Joly P; Bonneville M; Potaux L; Moreau JF
J Infect Dis; 1999 Jan; 179(1):1-8. PubMed ID: 9841815
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection Severity.
Kaminski H; Ménard C; El Hayani B; Adjibabi AN; Marsères G; Courant M; Zouine A; Pitard V; Garrigue I; Burrel S; Moreau JF; Couzi L; Visentin J; Merville P; Déchanet-Merville J
J Infect Dis; 2021 Feb; 223(4):655-666. PubMed ID: 32622351
[TBL] [Abstract][Full Text] [Related]
7. Implication of gammadelta T cells in the human immune response to cytomegalovirus.
Déchanet J; Merville P; Lim A; Retière C; Pitard V; Lafarge X; Michelson S; Méric C; Hallet MM; Kourilsky P; Potaux L; Bonneville M; Moreau JF
J Clin Invest; 1999 May; 103(10):1437-49. PubMed ID: 10330426
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role.
Lafarge X; Merville P; Cazin MC; Bergé F; Potaux L; Moreau JF; Déchanet-Merville J
J Infect Dis; 2001 Sep; 184(5):533-41. PubMed ID: 11494158
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation.
Couzi L; Levaillant Y; Jamai A; Pitard V; Lassalle R; Martin K; Garrigue I; Hawchar O; Siberchicot F; Moore N; Moreau JF; Dechanet-Merville J; Merville P
J Am Soc Nephrol; 2010 Jan; 21(1):181-8. PubMed ID: 19713314
[TBL] [Abstract][Full Text] [Related]
10. The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation.
Knight A; Madrigal AJ; Grace S; Sivakumaran J; Kottaridis P; Mackinnon S; Travers PJ; Lowdell MW
Blood; 2010 Sep; 116(12):2164-72. PubMed ID: 20576814
[TBL] [Abstract][Full Text] [Related]
11. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
13. Early versus late acute antibody-mediated rejection in renal transplant recipients.
Dörje C; Midtvedt K; Holdaas H; Naper C; Strøm EH; Øyen O; Leivestad T; Aronsen T; Jenssen T; Flaa-Johnsen L; Lindahl JP; Hartmann A; Reisæter AV
Transplantation; 2013 Jul; 96(1):79-84. PubMed ID: 23632391
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction.
Shabir S; Smith H; Kaul B; Pachnio A; Jham S; Kuravi S; Ball S; Chand S; Moss P; Harper L; Borrows R
Am J Transplant; 2016 Apr; 16(4):1113-28. PubMed ID: 26603521
[TBL] [Abstract][Full Text] [Related]
15. Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.
Couzi L; Pitard V; Moreau JF; Merville P; Déchanet-Merville J
Front Immunol; 2015; 6():3. PubMed ID: 25653652
[TBL] [Abstract][Full Text] [Related]
16. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
17. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
[TBL] [Abstract][Full Text] [Related]
18. Murine Cytomegalovirus-induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.
Saunders U; Li M; Boddeda SR; Maher S; Ghere J; Kaptsan I; Dhital R; Velazquez V; Guo L; Chen B; Zeng Q; Schoeb TR; Cianciolo R; Shimamura M
Transplantation; 2021 Aug; 105(8):1718-1729. PubMed ID: 33214535
[TBL] [Abstract][Full Text] [Related]
19. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
20. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells.
Sumitran-Karuppan S; Tyden G; Reinholt F; Berg U; Moller E
Transpl Immunol; 1997 Dec; 5(4):321-7. PubMed ID: 9504155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
